Gyre Therapeutics Stock Forward View - Accumulation Distribution
| GYRE Stock | 8.09 0.12 1.46% |
Gyre Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Gyre Therapeutics stock prices and determine the direction of Gyre Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Gyre Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The RSI of Gyre Therapeutics' share price is at 55. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Gyre Therapeutics, making its price go up or down. Momentum 55
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.662 | EPS Estimate Current Year 0.15 | EPS Estimate Next Year 0.1833 | Wall Street Target Price 18 | EPS Estimate Current Quarter (0.02) |
Using Gyre Therapeutics hype-based prediction, you can estimate the value of Gyre Therapeutics from the perspective of Gyre Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Gyre Therapeutics using Gyre Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Gyre using crowd psychology based on the activity and movement of Gyre Therapeutics' stock price.
Gyre Therapeutics Implied Volatility | 2.61 |
Gyre Therapeutics' implied volatility exposes the market's sentiment of Gyre Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gyre Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gyre Therapeutics stock will not fluctuate a lot when Gyre Therapeutics' options are near their expiration.
Gyre Therapeutics after-hype prediction price | USD 8.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Gyre Therapeutics to cross-verify your projections. Open Interest Against 2026-04-17 Gyre Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Gyre Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Gyre Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Gyre Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Gyre Therapeutics' open interest, investors have to compare it to Gyre Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Gyre Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Gyre. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Gyre Therapeutics Additional Predictive Modules
Most predictive techniques to examine Gyre price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Gyre using various technical indicators. When you analyze Gyre charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 3039.48 | 0.0339 |
| Check Gyre Therapeutics Volatility | Backtest Gyre Therapeutics | Information Ratio |
Gyre Therapeutics Trading Date Momentum
| On February 01 2026 Gyre Therapeutics was traded for 8.09 at the closing time. The top price for the day was 8.25 and the lowest listed price was 7.97 . There was no trading activity during the period 0.0. Lack of trading volume on February 1, 2026 did not cause price change. The overall trading delta against the current closing price is 0.12% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Gyre Therapeutics to competition |
Other Forecasting Options for Gyre Therapeutics
For every potential investor in Gyre, whether a beginner or expert, Gyre Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Gyre Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Gyre. Basic forecasting techniques help filter out the noise by identifying Gyre Therapeutics' price trends.Gyre Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gyre Therapeutics stock to make a market-neutral strategy. Peer analysis of Gyre Therapeutics could also be used in its relative valuation, which is a method of valuing Gyre Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Gyre Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Gyre Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gyre Therapeutics shares will generate the highest return on investment. By undertsting and applying Gyre Therapeutics stock market strength indicators, traders can identify Gyre Therapeutics entry and exit signals to maximize returns.
Gyre Therapeutics Risk Indicators
The analysis of Gyre Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Gyre Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gyre stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.53 | |||
| Semi Deviation | 3.2 | |||
| Standard Deviation | 3.74 | |||
| Variance | 13.96 | |||
| Downside Variance | 10.66 | |||
| Semi Variance | 10.27 | |||
| Expected Short fall | (2.77) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Gyre Therapeutics
The number of cover stories for Gyre Therapeutics depends on current market conditions and Gyre Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Gyre Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Gyre Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Gyre Therapeutics Short Properties
Gyre Therapeutics' future price predictability will typically decrease when Gyre Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Gyre Therapeutics often depends not only on the future outlook of the potential Gyre Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Gyre Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 102.3 M | |
| Cash And Short Term Investments | 26.7 M |
Check out Historical Fundamental Analysis of Gyre Therapeutics to cross-verify your projections. For information on how to trade Gyre Stock refer to our How to Trade Gyre Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Will Biotechnology sector continue expanding? Could Gyre diversify its offerings? Factors like these will boost the valuation of Gyre Therapeutics. Market participants price Gyre higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Gyre Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.662 | Earnings Share 0.04 | Revenue Per Share | Quarterly Revenue Growth 0.199 | Return On Assets |
Understanding Gyre Therapeutics requires distinguishing between market price and book value, where the latter reflects Gyre's accounting equity. The concept of intrinsic value—what Gyre Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Gyre Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Gyre Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gyre Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Gyre Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.